抗病毒AGO2-依赖的短毛RNAs的设计
Yuanyuan Bie1, Jieling Zhang2, Jiyao Chen3
1Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China; University of Chinese Academy of Sciences, Beijing 100049, China.
Virologica Sinica
|May 11, 2024
概括
这项研究引入了一种机器学习模型,用于设计高效的抗病毒短发针RNA (shRNA),以向RNA病毒. 这些新的AGO2-依赖的shRNAs (agshRNAs) 与传统siRNAs相比,显示出对EV71等病毒的增强效力.
科学领域:
- 分子生物学分子生物学
- 病毒学 病毒学
- 生物信息学是一种生物信息学.
- 药物发现 药物发现 药物发现
背景情况:
- RNA病毒爆发需要新的抗病毒疗法.
- 使用小干扰RNAs (siRNAs) 和短发针RNAs (shRNAs) 的RNA干扰 (RNAi) 显示出对抗病毒治疗的希望.
- AGO2-依赖的shRNA (agshRNA) 通过产生单链导向RNA,比传统的RNAi方法具有优势.
研究的目的:
- 开发一种机器学习模型,用于设计强大的抗病毒siRNA.
- 在机器学习预测的基础上设计和验证AGO2依赖的shRNAs (agshRNAs).
- 评估agshRNAs在体外和体内对各种RNA病毒的抗病毒疗效.
主要方法:
- 一个逻辑回归算法被应用到一个化学 siRNA 疗效数据集,以构建一个预测机器学习模型.
- 该模型用于设计针对多个RNA病毒 (EV71,ZIKV,DENV2,MHV,SARS-CoV-2) 的siRNA序列.
- 设计的siRNAs被转化为agshRNAs,其抗病毒功效被评估在受感染的细胞和体内.
主要成果:
- 成功开发了一种具有高预测能力的机器学习模型,用于siRNA有效性.
- 设计的agshRNAs对各种RNA病毒表现出强大的抗病毒活性,在对抗EV71的常规siRNA和shRNA方面表现优于常规siRNA和shRNA.
- 据证实,agshRNA的抗病毒作用依赖于AGO2,并且在体内具有功能.
结论:
- 这项研究提出了一种新的机器学习引导方法,用于设计高效的抗病毒agshRNAs.
- 开发的策略允许定制设计强大的agshRNAs,以对抗RNA病毒感染.
- agshRNAs代表了一个有前途的下一代抗病毒治疗策略.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Small interfering RNAs (siRNA)
3.5K
3.5K
piRNA - Piwi-interacting RNAs
6.8K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.8K


